Robert Rissmann, PhD
Centre for Human Drug Research · CHDR
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Robert Rissmann, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 08:23 UTC. Open this list on ClinicalTrials.gov
- N/ANCT05827107 · Skin Barrier and Microbiome of CTCL PatientsCentre for Human Drug Research, Netherlands · completed · Lymphoma, T-Cell, Cutaneous · principal investigator
- N/ANCT04394936 · An Explorative Psoriasis Biomarker StudyCentre for Human Drug Research, Netherlands · terminated · Psoriasis Vulgaris · principal investigator
- Ph2NCT03688971 · Omiganan Twice a Day (BID) in Patients With Facial Seborrheic DermatitisMaruho Co., Ltd. · unknown · Seborrheic Dermatitis · principal investigator
- Ph2NCT03684772 · Topical Ionic Contra-Viral Therapy in Actinic KeratosisMaruho Co., Ltd. · unknown · Actinic Keratosis · principal investigator
- N/ANCT03433820 · Wound Healing in Healthy VolunteersCentre for Human Drug Research, Netherlands · completed · Wound Healing · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 08:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.